Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ABBOTT LABORATORIES ABT

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.


NYSE:ABT - Post by User

Post by ivosmithon Nov 27, 2023 12:45am
107 Views
Post# 35753830

Blood Gas and Electrolyte Analyzer Market Outlook 2023-2028

Blood Gas and Electrolyte Analyzer Market Outlook 2023-2028

According to the latest research report, the global blood gas and electrolyte analyzer market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.41% during 2023-2028.

Global Blood Gas and Electrolyte Analyzer Market Trends and Drivers:

The global market is being majorly driven by the rising incidence of chronic diseases, such as respiratory disorders, kidney diseases, and metabolic imbalances. In line with this, the growing geriatric population and the increasing focus on point-of-care testing are significantly contributing to the market's growth. Furthermore, continuous technological advancements have significantly improved the performance and functionality of blood gas and electrolyte analyzers. These devices now offer faster results, higher accuracy, and increased automation, making them more efficient and user-friendly. Additionally, the integration of data management systems and connectivity features has also streamlined workflow and enhanced data analysis capabilities.

Request a free sample copy of the report: https://www.imarcgroup.com/blood-gas-electrolyte-analyzer-market/requestsample

The escalating demand for personalized medicine is further catalyzing the market. Moreover, expanding healthcare infrastructure has increased access to healthcare services, particularly in emerging markets. This has led to a surge in demand for blood gas and electrolyte analyzers in hospitals, clinics, and diagnostic centers, further propelling market expansion. Besides, favorable regulatory frameworks and reimbursement policies across many countries have facilitated the adoption of blood gas and electrolyte analyzers. These policies encourage healthcare providers to invest in these devices, offering lucrative opportunities for the market.

<< Previous
Bullboard Posts
Next >>